BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 12388746)

  • 1. Caveolin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak-2/STAT5a signaling cascade.
    Park DS; Lee H; Frank PG; Razani B; Nguyen AV; Parlow AF; Russell RG; Hulit J; Pestell RG; Lisanti MP
    Mol Biol Cell; 2002 Oct; 13(10):3416-30. PubMed ID: 12388746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice.
    Wagner KU; Krempler A; Triplett AA; Qi Y; George NM; Zhu J; Rui H
    Mol Cell Biol; 2004 Jun; 24(12):5510-20. PubMed ID: 15169911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b.
    Aoki N; Matsuda T
    J Biol Chem; 2000 Dec; 275(50):39718-26. PubMed ID: 10993888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic ablation of caveolin-1 in mammary epithelial cells increases milk production and hyper-activates STAT5a signaling.
    Sotgia F; Schubert W; Pestell RG; Lisanti MP
    Cancer Biol Ther; 2006 Mar; 5(3):292-7. PubMed ID: 16418573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor activator of NF-kappaB ligand induction via Jak2 and Stat5a in mammary epithelial cells.
    Srivastava S; Matsuda M; Hou Z; Bailey JP; Kitazawa R; Herbst MP; Horseman ND
    J Biol Chem; 2003 Nov; 278(46):46171-8. PubMed ID: 12952963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling.
    Pezet A; Favre H; Kelly PA; Edery M
    J Biol Chem; 1999 Aug; 274(35):24497-502. PubMed ID: 10455112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin negatively regulates caveolin-1 gene expression in the mammary gland during lactation, via a Ras-dependent mechanism.
    Park DS; Lee H; Riedel C; Hulit J; Scherer PE; Pestell RG; Lisanti MP
    J Biol Chem; 2001 Dec; 276(51):48389-97. PubMed ID: 11602600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice.
    Matsumoto A; Seki Y; Kubo M; Ohtsuka S; Suzuki A; Hayashi I; Tsuji K; Nakahata T; Okabe M; Yamada S; Yoshimura A
    Mol Cell Biol; 1999 Sep; 19(9):6396-407. PubMed ID: 10454585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways.
    Wu W; Coss D; Lorenson MY; Kuo CB; Xu X; Walker AM
    Biochemistry; 2003 Jun; 42(24):7561-70. PubMed ID: 12809512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine-like effects of prolactin in human mononuclear and polymorphonuclear leukocytes.
    Dogusan Z; Hooghe R; Verdood P; Hooghe-Peters EL
    J Neuroimmunol; 2001 Nov; 120(1-2):58-66. PubMed ID: 11694320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.
    Dif F; Saunier E; Demeneix B; Kelly PA; Edery M
    Endocrinology; 2001 Dec; 142(12):5286-93. PubMed ID: 11713228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of mammary gland factor/Stat5a during mammary gland development.
    Kazansky AV; Raught B; Lindsey SM; Wang YF; Rosen JM
    Mol Endocrinol; 1995 Nov; 9(11):1598-609. PubMed ID: 8584036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation and function of the cytokine-inducible SH-2 domain proteins, CIS and SOCS3, in mammary epithelial cells.
    Tonko-Geymayer S; Goupille O; Tonko M; Soratroi C; Yoshimura A; Streuli C; Ziemiecki A; Kofler R; Doppler W
    Mol Endocrinol; 2002 Jul; 16(7):1680-95. PubMed ID: 12089360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.
    Tomic S; Chughtai N; Ali S
    Mol Cell Endocrinol; 1999 Dec; 158(1-2):45-54. PubMed ID: 10630404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional rescue of Stat5a-null mammary tissue through the activation of compensating signals including Stat5b.
    Liu X; Gallego MI; Smith GH; Robinson GW; Hennighausen L
    Cell Growth Differ; 1998 Sep; 9(9):795-803. PubMed ID: 9751123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling.
    Minoo P; Zadeh MM; Rottapel R; Lebrun JJ; Ali S
    Blood; 2004 Feb; 103(4):1398-407. PubMed ID: 14551136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue.
    Liu X; Robinson GW; Gouilleux F; Groner B; Hennighausen L
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8831-5. PubMed ID: 7568026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice.
    Williams TM; Cheung MW; Park DS; Razani B; Cohen AW; Muller WJ; Di Vizio D; Chopra NG; Pestell RG; Lisanti MP
    Mol Biol Cell; 2003 Mar; 14(3):1027-42. PubMed ID: 12631721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined loss of INK4a and caveolin-1 synergistically enhances cell proliferation and oncogene-induced tumorigenesis: role of INK4a/CAV-1 in mammary epithelial cell hyperplasia.
    Williams TM; Lee H; Cheung MW; Cohen AW; Razani B; Iyengar P; Scherer PE; Pestell RG; Lisanti MP
    J Biol Chem; 2004 Jun; 279(23):24745-56. PubMed ID: 15044451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin and insulin synergize to regulate the translation modulator PHAS-I via mitogen-activated protein kinase-independent but wortmannin- and rapamycin-sensitive pathway.
    Barash I
    Mol Cell Endocrinol; 1999 Sep; 155(1-2):37-49. PubMed ID: 10580837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.